CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $71,502,000 | +3.0% | 10,200,000 | +21.8% | 1.25% | -7.1% |
| Q1 2022 | $69,404,000 | +7.1% | 8,372,000 | -12.5% | 1.34% | +26.5% |
| Q4 2021 | $64,802,000 | +22.3% | 9,572,000 | -4.3% | 1.06% | +18.2% |
| Q3 2021 | $53,000,000 | -7.8% | 10,000,000 | 0.0% | 0.90% | -12.7% |
| Q2 2021 | $57,500,000 | +24.7% | 10,000,000 | 0.0% | 1.03% | -2.7% |
| Q1 2021 | $46,100,000 | +38.0% | 10,000,000 | 0.0% | 1.06% | -6.9% |
| Q4 2020 | $33,400,000 | +12.5% | 10,000,000 | 0.0% | 1.14% | +5.5% |
| Q3 2020 | $29,700,000 | +3.7% | 10,000,000 | +61.3% | 1.08% | -14.3% |
| Q2 2020 | $28,644,000 | +37.8% | 6,200,000 | +14.8% | 1.26% | -2.3% |
| Q1 2020 | $20,790,000 | +8.7% | 5,400,000 | +5.9% | 1.29% | +16.6% |
| Q4 2019 | $19,125,000 | -0.4% | 5,100,000 | +2.0% | 1.10% | -8.8% |
| Q2 2019 | $19,200,000 | +147.7% | 5,000,000 | +228.9% | 1.21% | +185.4% |
| Q1 2019 | $7,752,000 | +192.5% | 1,520,000 | +10.1% | 0.42% | +110.9% |
| Q4 2018 | $2,650,000 | -58.1% | 1,380,000 | -17.5% | 0.20% | -47.0% |
| Q3 2018 | $6,320,000 | +19.2% | 1,672,000 | -1.6% | 0.38% | +9.5% |
| Q2 2018 | $5,304,000 | – | 1,700,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |